Spotlights

Oncology

Frizzled-7-targeting antibody (SHH002-hu1) potently suppresses non–small-cell lung cancer...

Non-small-cell lung cancer (NSCLC) makes up for ~85% of lung cancer patients, which is the most frequent cause of cancer-related death worldwide. Although, new targeted therapies and personalised medicine have improved outcome, most patients eventually...

GI Toxicity

Zymosan-A promotes the regeneration of intestinal stem cells...

The intestinal epithelium is characterised by intense self-renewal which is accomplished by intestinal stem cells (ISCs), located at the base of the crypts.  Beyond normal tissue homeostasis, these cells play a major role in the...